Dr. Nishith Vaddeboina is a leading Colorectal Cancer specialist in Hyderabad, Telangana, providing evidence-based oncology care at Nallagandla, Banjara Hills, and across India. Book a consultation for personalised diagnosis, treatment planning, and second opinions.

What is Colorectal Cancer?

Colorectal cancer develops in the colon or rectum and often begins as polyps that become malignant over time. Screening can detect precancerous changes early, when treatment is most effective.

Risk Factors

  • Family history or inherited syndromes (Lynch syndrome, FAP)
  • Inflammatory bowel disease
  • Diet high in processed meat and low in fibre
  • Smoking, obesity, and sedentary lifestyle

Symptoms

  • Change in bowel habits or stool shape
  • Blood in stool or rectal bleeding
  • Abdominal pain, bloating, or unexplained anaemia
  • Unintentional weight loss

Screening and Diagnosis

Colonoscopy remains the gold standard for screening and diagnosis. Staging with imaging and pathology guides decisions on surgery, chemotherapy, targeted therapy, and immunotherapy (especially in MSI-high tumours).

Treatment Options

  • Surgery for localised disease
  • Adjuvant chemotherapy for high-risk stages
  • Targeted therapy for metastatic disease with specific mutations
  • Immunotherapy for MSI-high or dMMR colorectal cancer

When to Consult a Specialist

Consult if you have rectal bleeding, persistent bowel changes, a positive screening test, or a confirmed diagnosis requiring treatment planning.

Our Approach to Colorectal Cancer Care

Dr. Nishith Vaddeboina manages colorectal cancer with a stage-based approach — from adjuvant chemotherapy after surgery to targeted and immunotherapy for advanced MSI-high or RAS-mutated tumours in Hyderabad.

  • MSI/MMR and RAS/BRAF testing for treatment selection
  • Neoadjuvant therapy for locally advanced rectal cancer
  • Palliative systemic therapy for metastatic disease
  • Surveillance planning after curative treatment

Why it Matters

Colorectal cancer screening saves lives. Blood in stool, changes in bowel habits, or a family history of colorectal cancer should prompt early colonoscopy and specialist consultation.

Why Choose Dr. Nishith Vaddeboina in Hyderabad?

  • Board-certified Medical Oncologist with expertise in advanced cancer treatments
  • Personalised treatment plans based on cancer type, stage, and biomarker testing
  • Care at leading hospitals in Hyderabad, Nallagandla, and Banjara Hills
  • Compassionate support for patients and families throughout treatment
  • Second opinions and treatment planning for complex or advanced cancers

Areas We Serve in Telangana

Dr. Nishith Vaddeboina treats patients from Hyderabad, Nallagandla, Banjara Hills, Gachibowli, Miyapur, Kukatpally, Secunderabad, Madhapur, Hitech City, and across Telangana and India. International patients are also welcome for expert oncology consultation.

Book Your Consultation Today

If you or a loved one needs expert cancer care, contact us at +91 8919791040 or email nishithvad@gmail.com. You can also book an appointment online with Dr. Nishith Vaddeboina for a comprehensive evaluation and personalised treatment plan.

Frequently Asked Questions

At what age should colorectal cancer screening start?

General screening often starts at 45�50 years, or earlier with family history or symptoms. Your doctor can recommend the right schedule.

Can colorectal cancer be cured?

Early-stage colorectal cancer has high cure rates with surgery and appropriate adjuvant treatment when indicated.

Who treats colorectal cancer in Hyderabad?

Dr. Nishith Vaddeboina treats colon and rectal cancer in Hyderabad with chemotherapy, targeted therapy, and immunotherapy for MSI-high or dMMR tumours.

What are the warning signs of colorectal cancer?

Rectal bleeding, persistent bowel changes, abdominal pain, unexplained anaemia, and unintentional weight loss should be evaluated promptly by a specialist.

What treatment options are available for colorectal cancer?

Treatment may include surgery, adjuvant chemotherapy, targeted therapy for specific mutations, and immunotherapy for MSI-high or dMMR colorectal cancer.